Revvity is trading at $168.52, up +4.11%, with no verified catalyst identified for the intraday rise.
- No verified October 28 company announcement or credible report directly explains the move; product and collaboration stories in search results were based on earlier announcements.
- Third-quarter results are scheduled for November 3, 2026; that upcoming report does not explain today’s move.
- Major indices are nearly flat in the supplied market context, so broad-market direction does not clearly account for the gain.